Future Science OA

Scope & Guideline

Connecting researchers to shape tomorrow's science.

Introduction

Welcome to your portal for understanding Future Science OA, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2056-5623
PublisherFUTURE SCI LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2015 to 2024
AbbreviationFUTUR SCI OA / Futur. Sci. OA
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNITED HOUSE, 2 ALBERT PL, LONDON N3 1QB, ENGLAND

Aims and Scopes

The journal 'Future Science OA' aims to publish high-quality, peer-reviewed research that contributes to the advancement of knowledge across various scientific disciplines, particularly in health sciences, biomedical research, and pharmacology. Its scope encompasses a wide range of topics, methodologies, and innovative approaches to address contemporary challenges in healthcare and medicine.
  1. Translational Medicine and Clinical Research:
    Focuses on bridging laboratory research and clinical practice, emphasizing studies that translate findings into real-world healthcare solutions.
  2. Innovative Therapeutics and Drug Development:
    Covers research on new therapeutic agents, drug delivery systems, and novel treatment strategies for various diseases, highlighting advancements in pharmacology and biotechnology.
  3. Public Health and Epidemiology:
    Addresses public health issues, disease prevalence, and the impact of social determinants on health, with a strong emphasis on community health interventions and epidemiological studies.
  4. Artificial Intelligence and Computational Biology:
    Explores the integration of AI and machine learning into biomedical research, including drug discovery, diagnostics, and personalized medicine.
  5. Cancer Research and Oncology:
    Includes studies on cancer biology, treatment modalities, prognosis, and innovative therapies, reflecting a commitment to combat cancer through research.
  6. Immunology and Infectious Diseases:
    Investigates immune responses, vaccine development, and the pathogenesis of infectious diseases, including the impact of recent pandemics.
Recent publications in 'Future Science OA' exhibit a clear trend towards emerging themes that reflect current challenges and advancements in the scientific community. These themes not only highlight innovative research but also respond to global health crises and technological advancements.
  1. COVID-19 Research and Its Implications:
    A significant increase in research related to COVID-19, including vaccine development, epidemiology, and long-term effects, demonstrating the journal's responsiveness to ongoing global health challenges.
  2. Integrative Approaches in Health Sciences:
    Growing emphasis on interdisciplinary research that combines various fields such as genetics, microbiology, and public health to address complex health issues.
  3. Personalized Medicine and Genomics:
    A surge in studies focusing on personalized medicine, including genetic profiling and tailored therapeutic strategies, reflecting advancements in genomic technologies.
  4. Nanotechnology and Drug Delivery Systems:
    Emerging interest in nanotechnology applications for drug delivery and therapeutic interventions, indicating a shift towards innovative and efficient treatment modalities.
  5. Mental Health and Psychosocial Aspects of Disease:
    Increasing focus on the psychological impact of diseases, particularly in the context of chronic illnesses and the effects of the COVID-19 pandemic on mental health.

Declining or Waning

Over the past few years, certain research themes within 'Future Science OA' have shown a decline in publication frequency, indicating a shift in focus towards more contemporary and pressing scientific inquiries.
  1. Traditional Pharmacology Studies:
    There has been a noticeable reduction in the publication of studies focused solely on traditional pharmacology without the integration of novel therapeutic approaches or technologies.
  2. Basic Science Research without Clinical Application:
    Research papers that focus exclusively on basic science without a clear translational aspect or clinical relevance appear to be waning, reflecting a preference for studies that can be applied in real-world settings.
  3. Single-Disease Focus Studies:
    The journal is moving away from studies that concentrate on single diseases without considering comorbidities or broader health implications, favoring interdisciplinary approaches that consider multiple health factors.

Similar Journals

Journal of Pharmaceutical Health Care and Sciences

Bridging disciplines to elevate pharmaceutical practices.
Publisher: BMCISSN: 2055-0294Frequency: 1 issue/year

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

New Armenian Medical Journal

Shaping the Future of Medicine Through Rigorous Research.
Publisher: YEREVAN STATE MEDICAL UNIVISSN: 1829-0825Frequency: 4 issues/year

New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

M S-MEDECINE SCIENCES

Unveiling critical advancements in biochemistry and medicine.
Publisher: EDP SCIENCES S AISSN: 0767-0974Frequency: 12 issues/year

M S-MEDECINE SCIENCES, published by EDP SCIENCES S A, is an esteemed journal based in France dedicated to the fields of biochemistry, genetics, and medicine. With an ISSN of 0767-0974 and an E-ISSN of 1958-5381, this journal has been a platform for scholarly communication since its inception in 1990 and continues to present critical advancements in these scientific domains, aiming to bridge theoretical research with practical applications. Despite its current Q4 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, the journal aspires to enhance its visibility and impact within the academic community. Researchers and professionals can benefit from a wealth of studies that contribute to the understanding of complex biological systems and medical innovations. Interested authors are encouraged to explore the journal's submission guidelines and contribute to the growing body of knowledge in these important fields.

Acta Naturae

Elevating Knowledge in Molecular Medicine and Beyond
Publisher: RUSSIAN FEDERATION AGENCY SCIENCE & INNOVATIONISSN: 2075-8251Frequency: 4 issues/year

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

Experimental and Therapeutic Medicine

Exploring groundbreaking methodologies in experimental medicine.
Publisher: SPANDIDOS PUBL LTDISSN: 1792-0981Frequency: 12 issues/year

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

BioScience Trends

Pioneering Insights in Molecular Biology and Social Health
Publisher: IRCA-BSSAISSN: 1881-7815Frequency: 6 issues/year

BioScience Trends, published by IRCA-BSSA, is a leading academic journal based in Japan that significantly contributes to the fields of biochemistry, genetics, molecular biology, and social health sciences. With an impactful Scopus ranking that places it in the 97th percentile for health social sciences and the 89th percentile for general biochemistry, this journal is an essential resource for researchers and professionals alike. Since its inception in 2007, BioScience Trends has fostered high-quality research dissemination and collaboration, offering a platform for innovative studies and insights that are vital for advancing knowledge in life sciences. Despite being a non-open access publication, it maintains rigorous standards and a reputable presence in the academic community, with an impressive categorization into Q1 and Q2 quartiles as of 2023. Researchers, students, and professionals seeking to stay at the forefront of scientific exploration and health advancements will find BioScience Trends to be an invaluable source for scholarly articles and emerging trends in their respective fields.

Global Journal of Medical Pharmaceutical and Biomedical Update

Empowering Knowledge in Medicine and Biomedical Sciences
Publisher: SCIENTIFIC SCHOLAR LLCISSN: Frequency: 1 issue/year

Global Journal of Medical Pharmaceutical and Biomedical Update, published by SCIENTIFIC SCHOLAR LLC, is a premier platform dedicated to advancing knowledge in the fields of medicine, pharmaceuticals, and biomedical sciences. With an E-ISSN of 2765-8910, this journal aims to foster innovative research and insightful discussions by providing open access to high-quality peer-reviewed articles. It serves as an invaluable resource for researchers, professionals, and students alike, ensuring that the latest advancements, methodologies, and findings are accessible to a diverse audience. Located at 50, Woodgreen Dr, Pittsford, NY 14534, the journal prioritizes the dissemination of critical information that addresses the evolving challenges faced in healthcare and biomedical research, ultimately contributing to the betterment of global health outcomes.

Biomedical Research and Therapy

Transforming research into impactful therapies for tomorrow.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

Biomed Research International

Advancing biomedical knowledge, one discovery at a time.
Publisher: HINDAWI LTDISSN: 2314-6133Frequency: 1 issue/year

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

Cell Reports Medicine

Empowering researchers with accessible, high-impact findings.
Publisher: CELL PRESSISSN: 2666-3791Frequency: 12 issues/year

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.